In the BioHarmony Drug Report Database
Darvadstrocel
Alofisel (darvadstrocel) is a cell pharmaceutical. Darvadstrocel was first approved as Alofisel on 2018-03-23. It has been approved in Europe to treat rectal fistula.
Trade Name
|
Alofisel |
|---|---|
Common Name
|
darvadstrocel |
ChEMBL ID
|
CHEMBL4298180 |
Indication
|
rectal fistula |
Drug Class
|
Image (chem structure or protein)
